Companies: 10,795·Total market cap: $144.5T
Laxai Pharma, Ltd.

Laxai Pharma, Ltd.

LAXAFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$475341
P/E Ratio
52W High
52W Low
Overview

Laxai Pharma, Ltd. (LAXAF) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · LAXAF · as of Jun 9, 2026

Key Statistics

EPS (TTM)laxaf eps ttm · laxaf earnings per shareEarnings history
PE Ratio (TTM)laxaf pe ratio ttm · laxaf price to earningsPE Ratio deep dive
Revenue (TTM)laxaf revenue ttm · laxaf annual revenueFull revenue history
Dividend YieldNo Dividenddoes laxaf pay dividends · laxaf dividend yieldDividend history
Shares Outstandinglaxaf shares outstanding · laxaf floatShares outstanding history
Next EarningsTBAlaxaf earnings date · laxaf next earningsEarnings history

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y-98.00%
5Y-88.89%

About Laxai Pharma, Ltd.

CEOJ. Ram Ajjarapu
IPO DateOct 31, 1994
Employees1
CountryUS
Website

Laxai Pharma, Ltd. is an American company that offers specialized contract research services. The firm provides extensive support throughout the entire pharmaceutical development process. Its areas of…

what is laxai pharma, ltd. · laxaf stock overview · laxai pharma, ltd. company profile · who is laxai pharma, ltd. ceo · laxaf OTC · laxai pharma, ltd. headquarters · laxai pharma, ltd. business segments

About Stock Overview & Key Data

Laxai Pharma, Ltd. (LAXAF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Oct 31, 1994. As of the latest trading session, LAXAF stock price is $0.00, with a market capitalization of $475,341. The stock has returned -98.00% over the past 12 months and +0.00% year-to-date.

Frequently Asked Questions

As of the latest trading session, Laxai Pharma, Ltd. (LAXAF) stock price is $0.00. The stock is traded on OTC under the ticker symbol LAXAF. The 52-week range is $1.00 – $4.00.

LAXAF stock priceLAXAF quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice